Item 1A. Risk Factors

There have been no material changes to the risk factors as previously disclosed in Part I, Item 1A of our Annual Report on Form 10-K for the year ended December 31, 2024.

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

During the quarter ended March 31, 2025, we fully utilized the remaining amount available under our $750 million share repurchase authorization that was publicly announced on May 7, 2024. On December 11, 2024, we publicly announced that our Board of Directors had approved an additional repurchase authorization in the amount of up to $750 million. The share repurchase authorization authorized the repurchase of our outstanding common stock in one or more open market and/or privately negotiated transactions, with no expiration date. Repurchase activity is typically executed in accordance with the safe-harbor provisions of Rule 10b-18 and Rule 10b5-1 promulgated under the Securities Exchange Act of 1934, as amended. The following table provides information regarding common stock repurchases during the quarter ended March 31, 2025:

(1) Of the shares repurchased in January 2025, 14,724 shares were repurchased under the May 7, 2024 share repurchase authorization, which fully utilized the May 2024 authorization. The remaining 11,276 shares were repurchased under the December 11, 2024 share repurchase authorization.